Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer

被引:58
作者
Zhou, Yujuan
Liao, Qianjin
Han, Yaqian
Chen, Jie
Liu, Zhigang
Ling, Hang
Zhang, Jing
Yang, Wenjuan
Oyang, Linda
Xia, Longzheng
Wang, Li
Wang, Heran
Xue, Lei
Wang, Hui [1 ,2 ]
Hu, Bingqiang [1 ,2 ]
机构
[1] Cent South Univ, Hunan Canc Hosp, Key Lab Translat Radiat Oncol, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
来源
JOURNAL OF CANCER | 2016年 / 7卷 / 14期
基金
中国国家自然科学基金;
关键词
non-small cell lung cancer; Rac1; epithelial-mesenchymal transition; prognosis; markers; radiotherapy; POTENTIAL THERAPEUTIC TARGET; RADIORESISTANT HEAD; GAMMA-IRRADIATION; INHIBITION; EXPRESSION; INVASION; REARRANGEMENTS; METASTASIS; STATISTICS; CARCINOMA;
D O I
10.7150/jca.16198
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Ras-related C3 botulinum toxin substrate1(Rac1) and epithelial mesenchymal transition (EMT) are key therapeutic targets in cancer. We investigated the clinical significance of Rac1 and markers of EMT expression in non-small cell lung cancer (NSCLC), and their possible correlation with EMT phenotype. Methods: Immunohistochemistry was used to assess the expression of Rac1, Snail1, Twist1, N-cadherin (N-cad), Vimentin (Vim), and E-cadherin (E-cad) in 153 NSCLC paraffin-embedded specimens and 45 normal specimens adjacent to tumors. The correlation of Rac1 and EMT markers with clinicopathological characteristics and the relationship between the protein levels and progression-free survival (PFS) and overall survival (OS) were analyzed. Results: Compared with non-tumor tissues, the NSCLC tissues showed marked elevation in the levels of Rac1, Snail1, Twist1, N-cad, and Vim levels, whereas the E-cad levels were significantly decreased (P < 0.05). The aberrant expression of Rac1 and EMT markers was significantly associated with TNM stage and metastasis (P < 0.05). Increased expression of Rac1 may be associated with poor OS and PFS compared with low expression (P<0.001 and P=0.004). Significant correlations were observed between the EMT markers expressed and OS or PFS(P<0.01). In addition, multivariate analysis indicated that the expression of Rac1, Snail1, Twist1, N-cad, Vim, and E-cad was an independent prognostic factor in NSCLC. Interestingly, Rac1 expression was positively correlated with Snail1, Twist1, N-cad, and Vim levels (r=0.563, r=0.440, r=0.247 r=0.536, P<0.01, respectively) and negatively correlated with E-cad levels (r=-0.464, P<0.001) in NSCLC tissues. Rac1, Twist, Snail1, Vim and N-cad were highly expressed in lung cancer patients resistant to radiotherapy, while E-cad was poorly expressed. Conclusion: Rac1 may promote NSCLC progression and metastasis via EMT, which may be considered as a potential therapeutic target.
引用
收藏
页码:2100 / 2109
页数:10
相关论文
共 50 条
[21]   RAC1 overexpression promotes the proliferation, migration and epithelial-mesenchymal transition of lens epithelial cells [J].
Su, Jing ;
Li, Hong .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09) :10760-10767
[22]   Overexpression of PSAT1 is Correlated with Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer [J].
Li, Hongmu ;
Wu, Chun ;
Chang, Wuguang ;
Zhong, Leqi ;
Gao, Wuyou ;
Zeng, Mingyue ;
Wen, Zhesheng ;
Mai, Shijuan ;
Chen, Youfang .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (10)
[23]   Decreased SARI expression predicts poor prognosis of Chinese patients with non-small cell lung cancer [J].
Zhou, Ren-Jie ;
Shi, Zhong ;
Zhou, Kun ;
Wang, Hai-Dong ;
Zhang, Guo-Qiang ;
Li, Xue-Tao ;
Xu, Jian-Ping .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (10) :2056-2063
[24]   RETRACTED: Circ_0017247 accelerates epithelial-mesenchymal transition in non-small cell lung cancer (Retracted Article) [J].
Li, C. -H. ;
Wang, Y. -B. ;
Chen, K. -B. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 :256-263
[25]   Downregulation of ARID1A is correlated with poor prognosis in non-small cell lung cancer [J].
Wang, Tao ;
Guo, Jinyan ;
Liu, Wenhua ;
Guo, Qi ;
Cheng, Lvhuan ;
Zheng, Renshan ;
Hu, Xinchun .
TRANSLATIONAL CANCER RESEARCH, 2020, 9 (08) :4896-4905
[26]   Overexpression of immunohistochemical RhoA associated with poor prognosis in operable non-small cell lung cancer [J].
Lou, Ming ;
Gao, Zhao-Jia ;
Zhu, Tao ;
Mao, Xiao-Liang ;
Yuan, Kai ;
Tong, Ji-Chun .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (06) :7577-7584
[27]   MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer [J].
Wang, Yu-zhou ;
Wu, Kun-peng ;
Wu, Ai-bing ;
Yang, Zhi-cheng ;
Li, Jin-mei ;
Mo, Yan-li ;
Xu, Meng ;
Wu, Bin ;
Yang, Zhi-xiong .
TUMOR BIOLOGY, 2014, 35 (10) :9815-9821
[28]   Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer [J].
Gu, Jie ;
Ding, Jian-yong ;
Lu, Chun-lai ;
Lin, Zong-wu ;
Chu, Yi-wei ;
Zhao, Guang-yin ;
Guo, Jing ;
Ge, Di .
LUNG CANCER, 2013, 81 (02) :259-265
[29]   GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer [J].
Feng, Yong ;
Li, Na ;
Ren, Yi .
CANCER MANAGEMENT AND RESEARCH, 2022, 14 :2419-2428
[30]   Overexpression of miR-425-5p is associated with poor prognosis and tumor progression in non-small cell lung cancer [J].
Fu, Yongxing ;
Li, Yuanyuan ;
Wang, Xiaoyan ;
Li, Feng ;
Lu, Yugang .
CANCER BIOMARKERS, 2020, 27 (02) :147-156